SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
Review
[키워드] Abstract
ACE-2, Angiotensin-converting enzyme 2
AKI, acute kidney injury
Ang II, Angiotensin II
BALF, Broncho alveolar lavage fluid
cGMP, Good Manufacturing Practice
Characteristics
coronavirus disease 19
COVID-19
COVID-19 infection
COVID-19, Coronavirus disease of 2019
CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats
CRS, Cytokine release syndrome
CT, Computed tomography
CT, Cycle threshold
current
Cytokine storm
DENV, dengue virus
develop
diagnostic tests
dimension
drugs
emerging variants
FDA, Food and Drug Administration
FNR, False‐negative rate
Genome
GGOs, Ground-glass opacities
global effort
HAT, Human airway trypsin-like protease
health emergency
Health Organization
HIV, Human immunodeficiency virus
IBV, infectious bronchitis virus
ICU, Intensive care unit
IL, interleukin
immune response
immune responses
Immunity
include
Infection
International
JEV, Japanese encephalitis virus
lack
LAMP, Loop-mediated isothermal amplification
LF, Lactoferrin
mechanism
MIP1α, Macrophage inflammatory protein 1α
MRI, Magnetic resonance imaging
MSC, Mesenchymal Stem Cells
Mutation
mutations
NCD, Newcastle disease virus
new virus
NP, nasopharyngeal
NSPs, Nonstructural proteins
OP, Oropharyngeal
pandemic
Pathogenesis
pathogenicity
Potential treatment
Prevent
problem
RAS, Renin-angiotensin system
RBD, Receptor binding-domain
RdRp, RNA-dependent RNA polymerases
Reinfection
Research
resulting
SARS-CoV
SARS-CoV-2
SARS-COV-2, severe acute respiratory syndrome coronavirus-2
severity
TGF, Transforming growth factor
Th17, T helper 17
the disease
the SARS-CoV-2
therapeutic
therapy
Transmissibility
treat
Vaccine
vaccine candidate
Vaccine development
Vaccines
variant
variants
variants of SARS-CoV-2
virus
VLPs, Virus-like particles
VTM, Viral transport medium
while
WHO
WNV, West Nile virus
[DOI] 10.1016/j.intimp.2021.108232 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.intimp.2021.108232 PMC 바로가기 [Article Type] Review